Alzheimer's disease was first diagnosed on November 3, 1906. One hundred years after its first diagnosis, researchers are now focusing on neuroscience, immunology and vaccine research in an effort to understand the manner in which AD develops and progresses. Researchers at the Yerkes National Primate Research Center, Emory University, feel that this study would help to advance the treatment and prevention of this progressive brain disorder. About 20 million Americans are currently affected by AD, which gradually destroys memory and the ability to learn, reason, make judgments and communicate.
"The Yerkes Research Center has developed four major areas of Alzheimer's research critical to identifying preventions and treatments to slow the progression or stop the onset of this devastating disease," said Stuart Zola, director of the center. "Along with investigating potential Alzheimer's disease vaccines, our researchers are developing a transgenic model for the disease, conducting comparative aging studies and detecting early symptoms of the disease."